UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 25, 2013
| | NORTHWEST BIOTHERAPEUTICS, INC. | |
| | (Exact name of registrant as specified in its charter) | |
| Delaware | 0-33393 | 94-3306718 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer ID Number) |
| 4800 Montgomery Lane, Suite 800, Bethesda, Maryland | 20814 |
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code | (240) 497-9024 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On November 25, 2013, we issued a press release announcing the closing of our recently announced underwritten public offering of our common stock and warrants to purchase shares of our common stock. The underwriters of the offering exercised in full their over-allotment option. We raised gross proceeds of $27.0 million in the offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
| 99.1 | Press release of Northwest Biotherapeutics, Inc. issued November 25, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | NORTHWEST BIOTHERAPEUTICS, INC. |
| | |
| | |
| Date: November 25, 2013 | /s/ Linda F. Powers | |
| | Linda F. Powers, Chief Executive Officer and Chairman |
